Welcome to the ValueWiki Myriad Genetics, Inc. (MYGN) article! Register for free or click the "edit" link to contribute!    

Myriad Genetics, Inc. (MYGN)

From ValueWiki

Jump to: navigation, search
This summary section needs content! Click Here to begin writing.
Have a question about Myriad Genetics, Inc.? Ask it on the Message Board or Chat Room
Visit the Apple, Inc. page for an example of a complete article.

Contents

Today 5d 3m 6m 1y 2y 5y Max



Funds w/ MYGN: 22
Rank: 330 / 351



Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.[1] Be bold!

News Feed

11/26/08 3:11 pm 4 Ways to Retire Well (at Motley Fool)
11/21/08 5:11 am Myriad Genetics upgraded by Citigroup (Briefing.com)
11/20/08 11:11 am Myriad wins European patent appeal on cancer test (at Reuters)
11/19/08 8:11 pm US biotech wins patent appeal (at FT.com)
11/19/08 10:11 am MYRIAD GENETICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles of Inc. or (EDGAR Online)
11/19/08 9:11 am FDA Involvement in Biotechnology Sector Discussed in Wall Street Transcript Report (Wall Street Transcript)
11/18/08 12:11 pm The Technical Indicator: U.S. markets teetering around five-year lows (at MarketWatch)
11/12/08 3:11 pm Affymetrix Gets Specific (at Motley Fool)
11/08/08 9:11 am MYRIAD GENETICS INC Financials (EDGAR Online Financials)
11/06/08 3:11 am Bullish Outlook for Preventive Medicine Companies Reflected in New ETF (at Seeking Alpha)
More News...

Risks

This section needs content! Click the blue edit link (to the right) to contribute.

Research Links

Myriad Genetics, Inc. Snapshot
Myriad Genetics, Inc. Leadership
Myriad Genetics, Inc. Fundamentals
Myriad Genetics, Inc. Technical Analysis
Myriad Genetics, Inc. Message Boards

Options

Notes

  1. This is a sample reference.
Personal tools